3 ms·
See https://astralcodexten.substack.com/p/adumbrations-of-aducanumab https://astralcodexten.substack.com/p/adumbrations-of-aducan... and https://www.econlib.org
by eru 4y ago
See https://astralcodexten.substack.com/p/adumbrations-of-aducanumab https://astralcodexten.substack.com/p/adumbrations-of-aducan... and https://www.econlib.org/archives/2017/01/why_are_drug_pr.html https://www.econlib.org/archives/2017/01/why_are_drug_pr.htm...
> If we simply went back to pre-1962 law, the FDA could still require proof of safety, but would not be able to require evidence on efficacy. This one change would allow drugs to be developed faster–often as much as 10 years faster. Market success would establish efficacy. Could there be ineffective drugs? Sure. But as doctors and patients learn, such drugs would disappear over time. This is nothing new; doctors and patients regularly evaluate drugs for efficacy. Clinical trials often show that perhaps only 20 percent, 40 percent, or 60 percent of patients benefit. Even when the FDA finally approves the drug as “safe and efficacious,” doctors must still evaluate the drug to find out how efficacious it is for each particular patient. In practice, an FDA certification of efficacy is just a starting point.
Btw Ivermectin is FDA approved. I am not sure why you bring that up?
- scoopertrooper 4y ago> Market success would establish efficacy. In the meantime, patients will be switching from drugs with known efficacy to wonder drugs with potentially no clinical evidence of having a medicinal effect. > Could there be ineffective drugs? Sure. But as doctors and patients learn, such drugs would disappear over time. Trying to do that piece meal won't work. You need controlled statistical studies to establish such things. > doctors must still evaluate the drug to find out how efficacious it is for each particular patient. Generally informed by subsequent clinical trials. They don't just go with their gut. > Btw Ivermectin is FDA approved. I am not sure why you bring that up? You know very well why. In fact it kind of makes my point. Patients are attempting to switch from a treatment regime with known efficacy (vaccines) to one with highly questionable efficacy (Ivermectin). If you follow through with your plans to deregulate the pharmaceuticals industry, you'll see a lot more of that.